• Find people
• Intranet

News

• Institutional news

  Jordi Mestres participates in one of the three projects funded by the ISCIII in the framework of the “International Rare Disease Research Consortium”

  The Carlos III Health Institute (ISCIII in Spanish) will fund, in the framework of the “International Rare Disease Research Consortium (IRDiRC)", three collaboration research projects in the whole of Spain, one of which is “DRUGS4RARE: drug repositioning for rare diseases”. This project is lead by Barcelona Science Park (PCB in Spanish), with the participation of the IMIM, together with the University of Santiago de Compostela (USC).

  Més informació "Jordi Mestres participates in one of the three projects funded by the ISCIII in the framework of the “International Rare Disease Research Consortium”"

• 23/01/2012 - Press release

  Identified a cause of resistance to colon cancer treatment

  Doctors and researchers of Hospital del Mar and IMIM point to an acquired mutation during treatment as the causative mechanism of therapeutic failure. This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer

  Més informació "Identified a cause of resistance to colon cancer treatment"

• 25/12/2011 - Press release

  Discovered the existence of neutrophils in the spleen

  For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital del Mar Research Institute) in collaboration with researchers from Mount Sinai in New York, has also made it possible to determine that these neutrophils have an immunoregulating role.

  Més informació "Discovered the existence of neutrophils in the spleen"

• 20/12/2011 - Events

  Bidding farewell to the participants of the PREDIMED study

  Last 14th December an event was held at the PRBB Auditorium; it was organized by the IMIM Group on Cardiovascular Risk and Nutrition to say goodbye to and thank the participants in the PREDIMED study, their involvement, availability and enthusiasm during the four years over which the project has developed (2003-2011).

  Més informació "Bidding farewell to the participants of the PREDIMED study"

• 04/12/2011 - Press release

  Discovery of a new reprogramming mechanism for tumor cells

  Nature Medicine publishes a pioneering study about a protein that regulates the expression of hundreds of genes that have a crucial role in the progression of pancreatic cancer, gliomas and possibly many other kinds of tumor. The study is directed by Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) and Raúl Méndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona).

  Més informació "Discovery of a new reprogramming mechanism for tumor cells"

• 18/11/2011 - General information

  IMIM already three years on twitter

  This November IMIM (Research Institute Hospital del Mar) celebrates its three years of history on twitter. This initiative began as a pioneer experience in the field of research to disseminate to the general public the news of the institution, the calendar of courses and conferences, the Inforecerca and everything that is published in the science bloc IMIMA'T. The twitter of the IMIM has been consolidated with success and currently has over 400 followers.

  Més informació "IMIM already three years on twitter"

• 15/11/2011 - Institutional news

  IMIM rated fifth in level of excellence among Spanish research institutions

  The 2011 SCImago Institutions Ranking World Report placed IMIM (Hospital del Mar Research Institute) in fifth place nationally with respect to excellence. This indicator shows institutes' ability to publish top articles in their scientific fields.The IMIM was also distinguished by having 73.7% of magazine articles in the top quartile and the fact that articles published by IMIM receive more than double the number of citations as the international average Més informació "L’IMIM és la cinquena institució de recerca espanyola en nivell d’excel·lència" -->

  Més informació "IMIM rated fifth in level of excellence among Spanish research institutions"

• 11/11/2011 - Press release

  Experts from the Hospital del Mar prove that having osteoarthritis leads to more fractures and falls in post-menopausal women

  A study lead by a team of researchers from the Hospital del Mar and its research institute, IMIM, concludes that post-menopausal women with osteoarthritis have a 20% greater risk of experiencing bone fractures due to osteoporosis and are at greater risk of falling –nearly 30% more than post-menopausal women without osteoarthritis

  Més informació "Experts from the Hospital del Mar prove that having osteoarthritis leads to more fractures and falls in post-menopausal women"

• 26/10/2011 - Press release

  New guidelines to report studies of genetic and molecular risk factors more accurate and ethical

  New guidelines which provide an easy to use checklist for the accurate and ethical reporting of studies involving genetic or molecular risk factors for disease have been proposed by a group of international researchers among them Miquel Porta, head of the group of Clinical and molecular epidemiology of cancer at IMIM (Hospital del Mar Research Institute), and are published in this week’s PLoS Medicine

  Més informació "New guidelines to report studies of genetic and molecular risk factors more accurate and ethical"

• 14/10/2011 - Institutional news

  The Pan American Games begin: The Anti- Doping Lab of IMIM moves to Mexico.

  During approximately one month, some twenty professionals of the Anti-Doping Control Laboratory of the IMIM (Hospital del Mar Research Institute) will be moving to Mexico to carry out the tests for anti-doping control at the games.

  Més informació "The Pan American Games begin: The Anti- Doping Lab of IMIM moves to Mexico."